{"id":"d67a95a1-a411-5da9-bea9-9fcfbbee8cc3","stable_key":"44737fa3-b335-53f4-a644-b9878d4416ac:creatine-diabetes-hba1c","predicate":"with_exercise_reduced","statement":"The between-group HbA1c difference favored creatine plus exercise by approximately 1.1 percentage points, with a 95% confidence interval of 0.4–1.9 percentage points lower.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"741565b9-12e4-5332-8db5-d0841541294e","mechanism_event_label":"Average long-term glucose exposure improved in this small combined-intervention trial.","subject":{"id":"9f5df558-ed3d-5cda-b5ca-0f90f7aa6a8c","slug":"creatine","display_name":"Creatine","entity_type_key":"small_molecule"},"object":{"id":"bb6a32db-7ce2-50b6-a53c-03bc271a2ead","slug":"glycated-hemoglobin","display_name":"Glycated hemoglobin / HbA1c","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"741565b9-12e4-5332-8db5-d0841541294e","stable_key":"44737fa3-b335-53f4-a644-b9878d4416ac:creatine-diabetes-hba1c-event","event_type":"observed_intervention","label":"Average long-term glucose exposure improved in this small combined-intervention trial.","description":"The between-group HbA1c difference favored creatine plus exercise by approximately 1.1 percentage points, with a 95% confidence interval of 0.4–1.9 percentage points lower.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"9f5df558-ed3d-5cda-b5ca-0f90f7aa6a8c","slug":"creatine","display_name":"Creatine","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"bb6a32db-7ce2-50b6-a53c-03bc271a2ead","slug":"glycated-hemoglobin","display_name":"Glycated hemoglobin / HbA1c","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/creatine-research/20881878.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"b3ba6f24e6aedc2c8220a6b50f5d315fc4f885740bc1934cf438cbe0865ace52\", \"start_char\": 0, \"end_char\": 1736, \"text_sha256\": \"b3ba6f24e6aedc2c8220a6b50f5d315fc4f885740bc1934cf438cbe0865ace52\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Twelve-week randomized double-blind trial with exercise in both arms","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Creatine 5 g/day plus exercise versus placebo plus exercise","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Small adjunct-to-exercise trial; no replacement for diabetes treatment or isolated creatine effect without exercise is established.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Creatine research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"creatine","display_name":"Creatine","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"25 adults with type 2 diabetes","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Average long-term glucose exposure improved in this small combined-intervention trial.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[creatine-p20881878] Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/20881878/ DOI: 10.1249/mss.0b013e3181fcee7d","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Blood glucose regulation and muscle GLUT4 localization","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"53d6f6d5-e5eb-50ab-89f6-1e4d5da21c10","evidence_kind":"source_excerpt","locator":"Lines 1010-1021","start_line":1010,"end_line":1021,"excerpt":"### creatine-diabetes-hba1c\nThe between-group HbA1c difference favored creatine plus exercise by approximately 1.1 percentage points, with a 95% confidence interval of 0.4–1.9 percentage points lower.\nCondition category: normal\nnutrient_topic: Creatine research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Average long-term glucose exposure improved in this small combined-intervention trial.\norganism: 25 adults with type 2 diabetes\ntissue_or_cell_type: Blood glucose regulation and muscle GLUT4 localization\nexperimental_model: Twelve-week randomized double-blind trial with exercise in both arms\nlimitations: Small adjunct-to-exercise trial; no replacement for diabetes treatment or isolated creatine effect without exercise is established.\nexposure: Creatine 5 g/day plus exercise versus placebo plus exercise\nevidence_span: {\"source_cache\": \"artifacts/creatine-research/20881878.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"b3ba6f24e6aedc2c8220a6b50f5d315fc4f885740bc1934cf438cbe0865ace52\", \"start_char\": 0, \"end_char\": 1736, \"text_sha256\": \"b3ba6f24e6aedc2c8220a6b50f5d315fc4f885740bc1934cf438cbe0865ace52\"}\n[creatine-p20881878] Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/20881878/ DOI: 10.1249/mss.0b013e3181fcee7d","model_system":"Twelve-week randomized double-blind trial with exercise in both arms","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [creatine-p20881878] Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/20881878/ DOI: 10.1249/mss.0b013e3181fcee7d","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"70358046-c5c3-5e9a-9fc9-eb01c3fff88b","stable_key":"import-44737fa3-b335-53f4-a644-b9878d4416ac","title":"Creatine: synthesis, transport, phosphocreatine energetics and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"548237d3e98a73a7dc02181807921fdd8b902adcee46248792258a761593eda9","revision_id":"88738255-8028-52fb-9c12-0fe92d8ce367","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}